These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25677664)

  • 1. Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists.
    Matsuda T; Okuda A; Watanabe Y; Miura T; Ozawa H; Tosaka A; Yamazaki K; Yamaguchi Y; Kurobuchi S; Koura M; Shibuya K
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1274-8. PubMed ID: 25677664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists.
    Koura M; Matsuda T; Okuda A; Watanabe Y; Yamaguchi Y; Kurobuchi S; Matsumoto Y; Shibuya K
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2668-74. PubMed ID: 25998501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and β-selectivity of liver X receptor agonist.
    Koura M; Yamaguchi Y; Kurobuchi S; Sumida H; Watanabe Y; Enomoto T; Matsuda T; Okuda A; Koshizawa T; Matsumoto Y; Shibuya K
    Bioorg Med Chem; 2016 Aug; 24(16):3436-46. PubMed ID: 27283790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting selective liver X receptor β agonists using multiple machine learning methods.
    Li Y; Wang L; Liu Z; Li C; Xu J; Gu Q; Xu J
    Mol Biosyst; 2015 May; 11(5):1241-50. PubMed ID: 25734698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR studies: designing potent and selective LXR agonists.
    Szewczyk JW; Huang S; Chin J; Tian J; Mitnaul L; Rosa RL; Peterson L; Sparrow CP; Adams AD
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3055-60. PubMed ID: 16529931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
    Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.
    Kick E; Martin R; Xie Y; Flatt B; Schweiger E; Wang TL; Busch B; Nyman M; Gu XH; Yan G; Wagner B; Nanao M; Nguyen L; Stout T; Plonowski A; Schulman I; Ostrowski J; Kirchgessner T; Wexler R; Mohan R
    Bioorg Med Chem Lett; 2015 Jan; 25(2):372-7. PubMed ID: 25435151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.
    Ullrich JW; Morris R; Bernotas RC; Travins JM; Jetter J; Unwalla R; Quinet E; Nambi P; Feingold I; Huselton C; Enroth C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 May; 20(9):2903-7. PubMed ID: 20382019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
    Zheng Y; Zhuang L; Fan KY; Tice CM; Zhao W; Dong C; Lotesta SD; Leftheris K; Lindblom PR; Liu Z; Shimada J; Noto PB; Meng S; Hardy A; Howard L; Krosky P; Guo J; Lipinski K; Kandpal G; Bukhtiyarov Y; Zhao Y; Lala D; Van Orden R; Zhou J; Chen G; Wu Z; McKeever BM; McGeehan GM; Gregg RE; Claremon DA; Singh SB
    J Med Chem; 2016 Apr; 59(7):3264-71. PubMed ID: 26990539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding probiotic Lactobacillus paracasei to Ossabaw pigs on a high-fat diet prevents cholesteryl-ester accumulation and LPS modulation of the Liver X receptor and inflammatory axis in alveolar macrophages.
    Trasino SE; Dawson HD; Urban JF; Wang TT; Solano-Aguilar G
    J Nutr Biochem; 2013 Nov; 24(11):1931-9. PubMed ID: 24060267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a new binding mode for a series of liver X receptor agonists.
    Kopecky DJ; Jiao XY; Fisher B; McKendry S; Labelle M; Piper DE; Coward P; Shiau AK; Escaron P; Danao J; Chai A; Jaen J; Kayser F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2407-10. PubMed ID: 22406115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages.
    Marino JP; Kallander LS; Ma C; Oh HJ; Lee D; Gaitanopoulos DE; Krawiec JA; Parks DJ; Webb CL; Ziegler K; Jaye M; Thompson SK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5617-21. PubMed ID: 19717304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists.
    Bernotas RC; Kaufman DH; Singhaus RR; Ullrich J; Unwalla R; Quinet E; Nambi P; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem; 2009 Dec; 17(23):8086-92. PubMed ID: 19853462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening.
    Temml V; Voss CV; Dirsch VM; Schuster D
    J Chem Inf Model; 2014 Feb; 54(2):367-71. PubMed ID: 24502802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
    Wrobel J; Steffan R; Bowen SM; Magolda R; Matelan E; Unwalla R; Basso M; Clerin V; Gardell SJ; Nambi P; Quinet E; Reminick JI; Vlasuk GP; Wang S; Feingold I; Huselton C; Bonn T; Farnegardh M; Hansson T; Nilsson AG; Wilhelmsson A; Zamaratski E; Evans MJ
    J Med Chem; 2008 Nov; 51(22):7161-8. PubMed ID: 18973288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRalpha and beta.
    Panday N; Benz J; Blum-Kaelin D; Bourgeaux V; Dehmlow H; Hartman P; Kuhn B; Ratni H; Warot X; Wright MB
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5231-7. PubMed ID: 16876993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional pharmacophore modeling of liver-X receptor agonists.
    Zhao W; Gu Q; Wang L; Ge H; Li J; Xu J
    J Chem Inf Model; 2011 Sep; 51(9):2147-55. PubMed ID: 21434646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
    Jia Y; Hoang MH; Jun HJ; Lee JH; Lee SJ
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4185-90. PubMed ID: 23769638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.